Ellis Medicine has opened the Nan and Hugh Murphy Interventional Procedures Suite at Ellis Hospital, enhancing pulmonary and ...
Silicosis, a deadly lung disease caused by breathing in kitchen stone dust, should by rights be on the wane since the advent ...
In a randomized clinical trial, vixarelimab demonstrates dose-dependent, long-term safety and efficacy in patients with ...
Continuing the hospital’s dedication and work in lung cancer and pulmonology, Ellis Medicine opened the Nan and Hugh Murphy ...
Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung ...
The FDA has approved Exdensur for add-on maintenance treatment of severe asthma characterized by an eosinophilic phenotype in patients aged 12 and older.
The FDA has approved an oral pellet formulation of Orladeyo® to prevent attacks of hereditary angioedema in pediatric patients.
Non-small cell lung cancer (NSCLC) remains the most prevalent type of lung cancer and a leading cause of cancer-related mortality worldwide. Surgical ...